Tuesday, January 17, 2023 3:31:42 PM
Endexx Announces Fiscal 2022 Year-End Financial Results
Jan. 17, 2023 8:30 AM ETEndexx Corporation (EDXC)
CAVE CREEK, AZ, Jan. 17, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Endexx Corporation (EDXC), a provider of innovative Hemp-derived wellness and nutritional products, today announced its fiscal 2022 annual results. Endexx restructured itself in August/September 2022 to optimize growth potential and expand its product offerings internationally for Fiscal 2023. The company showed a 96% increase in top-line revenue in fiscal 2022, while generating a gross profit of $503,009 in fiscal 2022 compared to a loss of $344,078 in the prior year. Endexx was able to reduce operating expenses by 23%, a reduction of $1,162,007.
Endexx 2022 Milestones and Highlights
Increased F/D/M shelf space:
Men’s Skincare and Grooming line launched in select Target and CVS stores nationwide.
Endexx grew from 4,000 Mass Retail stores to over 8,000 in fiscal 2022.
Endexx launched its premium Plant-Derived Skincare line on Amazon.com with reach to 13 countries.
Endexx garnered “top 2” in sales of CBD products in Mass Retail Pharmacy outlets in 2022 according to Nielsen Ratings.
Endexx expanded its retail footprint nationwide with its top selling balm and cream products in the “pain aisle” at Walgreens.
Endexx acquired a 51% interest in HYLA™ US, a company that specializes in non-nicotine, plant-based vape and consumable products for domestic and international markets.
“Fiscal 2022 reflected a year of expansion and recovery after two years of economic challenges associated with the economy and the pandemic,” stated CEO Todd Davis. Davis added, “Expansion of the national mass retail footprint put the company back on its growth path. We now have 5 of the top 8 “Mass Retailers” in the US as our customers. We anticipate continued top-line revenue growth, continued store expansion, and some of the challenges that we saw in Fiscal 2022 to moderate with our Hemp-Derived CBD products and skincare line. Non-nicotine, plant-based alternatives in the consumer product market provide for an extremely compelling outlook for Hyla US going forward. We believe Hyla’s revenues will grow exponentially this fiscal year, continuing into fiscal 2024 and 2025.”
www.endexx.com & www.cbdunlimited.com
www.tryhyla.com
Recent EDXC News
- Form SEC STAFF ACTION - SEC Staff Action: ORDER • Edgar (US Regulatory) • 09/19/2024 04:00:03 PM
- Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • InvestorsHub NewsWire • 03/27/2024 07:01:28 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM